Brooks Laboratories (NSE:BROOKS) EPS (Basic) : ₹-4.68 (TTM As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is Brooks Laboratories EPS (Basic)?

Brooks Laboratories's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was ₹-0.48. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹-4.68.

Brooks Laboratories's EPS (Diluted) for the three months ended in Mar. 2025 was ₹-0.48. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹-4.68.

Brooks Laboratories's EPS without NRI for the three months ended in Mar. 2025 was ₹-0.48. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was -4.68.

During the past 3 years, the average EPS without NRI Growth Rate was 21.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was 14.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Brooks Laboratories's highest 3-Year average EPS without NRI Growth Rate was 29.10% per year. The lowest was -38.70% per year. And the median was -2.65% per year.

Brooks Laboratories EPS (Basic) Historical Data

The historical data trend for Brooks Laboratories's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brooks Laboratories EPS (Basic) Chart

Brooks Laboratories Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

EPS (Basic)

Get a 7-Day Free Trial

-7.03

-7.67

-12.57

-7.67

-3.72

Brooks Laboratories Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EPS (Basic)	Get a 7-Day Free Trial															-3.77	-0.94	-1.51	-1.75	-0.48

Brooks Laboratories EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Brooks Laboratories's Basic EPS for the fiscal year that ended in Mar. 2025 is calculated as

Basic EPS (A: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-99.67	-	0)	/	26.793
	=	-3.72

Brooks Laboratories's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-14.58	-	0)	/	28.385
	=	-0.51

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-4.68

Brooks Laboratories (NSE:BROOKS) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Brooks Laboratories EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Brooks Laboratories's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Brooks Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Brooks Laboratories Ltd (NSE:BROOKS) » Definitions » EPS (Basic)

Traded in Other Exchanges

533543:India

Address

Off. Andheri Kurla Road, 201, The Summit Business Park, Behind Guru Nanak Petrol Pump, Andheri (East), Mumbai, MH, IND, 400 093

Website

https://www.brookslabs.net

Brooks Laboratories Ltd is an Indian company operating in the healthcare sector. The company is engaged in the formulation, development, production, and export of drugs and pharmaceuticals. The company operates under one segment: Pharmaceutical products including ingredients and intermediaries. It manufactures drugs in a variety of forms, including tablets, dry syrup, injections, liquid injections, dry powder injections, eye drops, and ear drops. Its products include carbapenem and penicillins.

Brooks Laboratories Headlines

No Headlines